1. Home
  2. ATRA vs STBX Comparison

ATRA vs STBX Comparison

Compare ATRA & STBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • STBX
  • Stock Information
  • Founded
  • ATRA 2012
  • STBX 2019
  • Country
  • ATRA United States
  • STBX Malaysia
  • Employees
  • ATRA N/A
  • STBX N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • STBX Advertising
  • Sector
  • ATRA Health Care
  • STBX Consumer Discretionary
  • Exchange
  • ATRA Nasdaq
  • STBX Nasdaq
  • Market Cap
  • ATRA 50.3M
  • STBX 51.1M
  • IPO Year
  • ATRA 2014
  • STBX 2022
  • Fundamental
  • Price
  • ATRA $10.61
  • STBX $1.24
  • Analyst Decision
  • ATRA Hold
  • STBX
  • Analyst Count
  • ATRA 5
  • STBX 0
  • Target Price
  • ATRA $26.88
  • STBX N/A
  • AVG Volume (30 Days)
  • ATRA 143.9K
  • STBX 394.0K
  • Earning Date
  • ATRA 11-12-2024
  • STBX 12-03-2024
  • Dividend Yield
  • ATRA N/A
  • STBX N/A
  • EPS Growth
  • ATRA N/A
  • STBX N/A
  • EPS
  • ATRA N/A
  • STBX N/A
  • Revenue
  • ATRA $100,439,000.00
  • STBX $12,213,183.00
  • Revenue This Year
  • ATRA $1,190.80
  • STBX N/A
  • Revenue Next Year
  • ATRA N/A
  • STBX N/A
  • P/E Ratio
  • ATRA N/A
  • STBX N/A
  • Revenue Growth
  • ATRA 2111.34
  • STBX 48.08
  • 52 Week Low
  • ATRA $6.50
  • STBX $1.05
  • 52 Week High
  • ATRA $39.50
  • STBX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 51.14
  • STBX 38.51
  • Support Level
  • ATRA $11.10
  • STBX $1.17
  • Resistance Level
  • ATRA $14.93
  • STBX $2.00
  • Average True Range (ATR)
  • ATRA 1.46
  • STBX 0.26
  • MACD
  • ATRA -0.14
  • STBX -0.01
  • Stochastic Oscillator
  • ATRA 24.48
  • STBX 20.00

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About STBX Starbox Group Holdings Ltd.

Starbox Group Holdings Ltd engages in developing cash rebate, digital advertising, and payment solution business ecosystem targeting micro, small, and medium enterprises. Through the firm's subsidiaries in Malaysia, it connects retail merchants with retail shoppers to facilitate transactions through cash rebates offered by retail merchants, provide digital advertising services to advertisers, and provide payment solution services to merchants. Substantially all of its current operations are located in Malaysia. It operates in five segments include Cash rebate, payment solution, and media booking, Advertising services, Software licensing and Production services, Marketing and Promotional campaign services segment.

Share on Social Networks: